Mika Endo

774 total citations
19 papers, 301 citations indexed

About

Mika Endo is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mika Endo has authored 19 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Mika Endo's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mika Endo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mika Endo collaborates with scholars based in Japan, United States and Netherlands. Mika Endo's co-authors include Tohru Ishikawa, Hideo Ishitsuka, Yutaka Tanaka, Yu Fukase, Noriaki Sawada, Eiji Kinoshita, Tohru Koike, Emiko Kinoshita‐Kikuta, Atsushi Yamada and Yoko Kayukawa and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Mika Endo

19 papers receiving 286 citations

Peers

Mika Endo

ONCOL

RNMI

SPECT

Roberto Diaz United States

Fergus Keane United States

Ely Cosino United States

Milan Král Czechia

Anca Năstase Romania

Yasuharu Mori Japan

Mesquita Rodrigues Portugal

Astrid Drenckhan Germany

Matthew White United States

Francesca Conti United States

Roberto Diaz United States

Mika Endo

118 ×0.7

ONCOL

104 ×0.8

36 ×0.5

RNMI

136 ×2.8

4 ×0.1

SPECT

Citations per year, relative to Mika Endo Mika Endo (= 1×) peers Roberto Diaz

Countries citing papers authored by Mika Endo

Since Specialization

Citations

This map shows the geographic impact of Mika Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Endo more than expected).

Fields of papers citing papers by Mika Endo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Endo. The network helps show where Mika Endo may publish in the future.

Co-authorship network of co-authors of Mika Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Endo. A scholar is included among the top collaborators of Mika Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Endo. Mika Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Komatsu, Shunichiro, Yoko Kayukawa, Yoko Miyazaki, et al.. (2022). Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial. Scientific Reports. 12(1). 12312–12312. 10 indexed citations

Sano, Yuji, Yumiko Azuma, Toshiaki Tsunenari, et al.. (2022). Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours. Nature Communications. 13(1). 5265–5265. 16 indexed citations

Kimura, Hidenori, et al.. (2020). N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 33. 127753–127753. 7 indexed citations

Shiraiwa, Hirotake, Atsushi Narita, Mika Kamata‐Sakurai, et al.. (2018). Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974. Methods. 154. 10–20. 42 indexed citations

Azuma, Yumiko, Yuji Sano, Toshiaki Tsunenari, et al.. (2018). Abstract 5609: ERY974, a novel T cell-redirecting bispecific antibody targeting glypican-3, shows antitumor activity in gastric cancer patient-derived xenograft models with varying glypican-3 expression. Cancer Research. 78(13_Supplement). 5609–5609. 2 indexed citations

Endo, Mika, Yasuko Kinoshita, Kenji Adachi, et al.. (2018). Abstract 2747: Anti-glypican-3 monoclonal antibody (codrituzumab/GC33/RO5137382) treatment enhances tumor infiltration of PD-L1-positive macrophages, and combination therapy with anti-PD-L1 monoclonal antibody promotes antitumor effects. Cancer Research. 78(13_Supplement). 2747–2747. 5 indexed citations

Endo, Mika, et al.. (2018). Bis-heteroleptic ruthenium(II) complex with 2-picolinamide: Synthesis, crystal structures, and spectroscopic study for anion recognition using the amide group. Inorganica Chimica Acta. 486. 304–313. 7 indexed citations

Sano, Yuji, Yumiko Azuma, Toshiaki Tsunenari, et al.. (2017). Abstract 3653: Combining ERY974, a novel T cell-redirecting bispecific antibody targeting glypican-3, with chemotherapy profoundly improved antitumor efficacy over its monotherapy in xenograft model. Cancer Research. 77(13_Supplement). 3653–3653. 2 indexed citations

Kameyama, Naoya, Kaoru Kobayashi, Shoko Shimizu, et al.. (2016). Involvement of ESE-3, epithelial-specific ETS factor family member 3, in transactivation of the ABCB1 gene via pregnane X receptor in intestine-derived LS180 cells but not in liver-derived HepG2 cells. Drug Metabolism and Pharmacokinetics. 31(5). 340–348. 5 indexed citations

10.

Kinoshita, Yasuko, Takahiro Ishiguro, Yuji Sano, et al.. (2016). Abstract 1482: Anti-GPC3 TRAB, a first-in-class T cell-redirecting bispecific antibody targeting glypican-3 with potent in vitro and in vivo antitumor efficacy against solid tumors. Cancer Research. 76(14_Supplement). 1482–1482. 1 indexed citations

11.

Ishiguro, Takahiro, Yasuko Kinoshita, Yuji Sano, et al.. (2016). Abstract DDT01-05: First-in-class T cell-redirecting bispecific antibody targeting glypican-3: a highly tumor-selective antigen. Cancer Research. 76(14_Supplement). DDT01–5. 3 indexed citations

12.

Endo, Mika. (2014). "The Word ‘Mixed’ without the ‘Indian’ Would Be Better": Virginia’s Racial Integrity Act and the Destruction of Indian Race in the Early Twentieth Century. 7(1). 92–107. 1 indexed citations

13.

Endo, Mika, Mitsue Sano, Tsutomu Fukuwatari, & Katsumi Shibata. (2011). Vitamin Contents in Rat Milk and Effects of Dietary Vitamin Intakes of Dams on the Vitamin Contents in Their Milk. Journal of Nutritional Science and Vitaminology. 57(3). 203–208. 1 indexed citations

14.

Endo, Mika, Masanori Miwa, Masako Ura, et al.. (2009). A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts. Cancer Chemotherapy and Pharmacology. 65(2). 363–371. 13 indexed citations

15.

Yoshida, Munehiro, et al.. (2008). Molybdenum and Chromium Concentrations in Breast Milk from Japanese Women. Bioscience Biotechnology and Biochemistry. 72(8). 2247–2250. 11 indexed citations

16.

Kinoshita‐Kikuta, Emiko, Eiji Kinoshita, Atsushi Yamada, Mika Endo, & Tohru Koike. (2006). Enrichment of phosphorylated proteins from cell lysate using a novel phosphate‐affinity chromatography at physiological pH. PROTEOMICS. 6(19). 5088–5095. 52 indexed citations

17.

Yamamoto, Yuko, et al.. (2004). The Influence which the Height of the Heel Gives the Gait during Pregnancy. Rigakuryoho Kagaku. 19(2). 107–110. 3 indexed citations

18.

Endo, Mika, Masanori Miwa, Hiroyuki Eda, et al.. (2003). Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. International Journal of Cancer. 106(5). 799–805. 8 indexed citations

19.

Endo, Mika, Yu Fukase, Noriaki Sawada, et al.. (1999). Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5?-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models. International Journal of Cancer. 83(1). 127–134. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact